Michael J. Fitzpatrick
52 IP cases indexed. Covers patent matters.
Cases Presided Over
52 cases indexed | Page 2 of 2
Avanos Medical, Inc. v.Stratus Medical, LLC
Avanos Medical successfully petitioned to institute IPR proceedings against Stratus Medical's patent, demonstrating a reasonable likelihood of success on obviousness grounds. The Board found sufficient evidence that the claimed RF neurotomy features could be achieved by combining existing prior art references.
Avanos Medical, Inc. v.Stratus Medical, LLC
The PTAB found all 29 challenged claims unpatentable by a preponderance of evidence. The Board rejected the Patent Owner's argument that the invention was limited to RF neurotomy, adopting Petitioner's broader view of 'thermal ablation systems.'
Avanos Medical, Inc. v.Stratus Medical, LLC
The PTAB found that the claims were unpatentable over Racz, Fitz, and Lee based on obviousness (103). The Board adopted Petitioner's broad definition of 'thermal ablation systems,' rejecting the Patent Owner's narrow focus on 'RF neurotomy.'
Avanos Medical, Inc. v.Stratus Medical, LLC
The PTAB issued a Final Written Decision finding that Claims 1-17 and 48-52 are unpatentable based on obviousness. The Board found that the combination of prior art references (Racz, Fitz, Lee) was an obvious modification to create functional RF neurotomy devices.
Avanos Medical, Inc. v.Stratus Medical, LLC
The PTAB issued a Final Written Decision finding all 27 challenged claims unpatentable based on obviousness over prior art (Racz, Fitz, Lee). The Board adopted the Petitioner's broad definition of POSA in the field of thermal ablation systems.
Medela LLC et al. v.M.E.A.C. Engineering Ltd.
Medela and M.E.A.C. Engineering settled their IPR dispute over patent 8,858,534 B2. The Board terminated the proceeding before any trial, keeping the settlement confidential.
Inari Agriculture, Inc. v.Corteva Agriscience LLC et al.
Inari Agriculture successfully petitioned to institute an IPR against Corteva Agriscience's GMO patents based on prior art from Barbour. The Board found a reasonable likelihood of prevailing regarding anticipation and obviousness over the cited publication, moving the case toward trial.
Inari Agriculture, Inc. v.Corteva Agriscience LLC et al.
The PTAB Board upheld the validity of U.S. Patent No. 8,901,378 B2 after finding that the TC1507 germplasm was publicly available prior to the application's filing date. The Board concluded that this availability satisfied priority requirements and prevented Barbour from qualifying as prior art under § 102.
Skechers U.S.A., Inc. v.Nike, Inc.
Skechers' IPR challenge against Nike regarding knit textile footwear was denied by the PTAB. The Board found no reasonable likelihood of prevailing on obviousness grounds, despite adopting the patent owner's claim construction for 'article of footwear.'
Skechers U.S.A., Inc. v.Nike, Inc.
The PTAB denied institution of an IPR petition filed by Skechers against Nike, finding the claims lacked reasonable likelihood of prevailing based on obviousness grounds (103). The Board adopted the Patent Owner's narrow construction of 'article of footwear,' which was critical to the denial.
Duration Media v.Rich Media Club LLC
The PTAB affirmed all ten claims of the ’329 ad‑viewability patent, finding Duration Media failed to prove obviousness over Krassner, Badros, and Harkins. Claim constructions on “render,” “replacement advertisement,” and the “in‑response‑to” step were adopted.
Duration Media v.Rich Media Club LLC
The PTAB denied the institution of Inter Partes Review (IPR) against Rich Media Club LLC's advertising patent. The Board found that Petitioner Duration Media lacked a reasonable likelihood of prevailing on grounds of obviousness (103).
Skechers U.S.A., Inc. v.Nike, Inc.
Skechers U.S.A., Inc.'s IPR challenge against Nike, Inc.'s footwear patent was denied by the PTAB due to failure to meet the reasonable likelihood of prevailing standard. The Board rejected key claim constructions and found that prior art references did not adequately disclose the claimed integral knit tongue feature.
Skechers U.S.A., Inc. v.Nike, Inc.
Skechers U.S.A., Inc.'s IPR challenge against Nike, Inc.'s footwear patent was denied by the PTAB. The Board found that Petitioner failed to meet the threshold burden of showing a reasonable likelihood of prevailing on any unpatentability challenge.
New Balance Athletics, Inc. v.Nike, Inc.
New Balance Athletics, Inc.'s IPR petition against Nike's footwear patent was denied by the PTAB. The Board found that Petitioner failed to demonstrate a reasonable likelihood of prevailing in its obviousness challenges over multiple prior art references.
Solventum Corporation v.M.E.A.C. Engineering Ltd.
Solventum Corporation and M.E.A.C. Engineering reached a settlement that led to the termination of IPR2024-01001 before any trial was instituted. The Board granted the motion to terminate and ordered the settlement agreement to remain confidential.
Solventum Corporation v.M.E.A.C. Engineering Ltd.
Solventum Corp. filed an IPR against M.E.A.C. Engineering’s patent 8,858,534. The parties settled before the Board could institute a trial, leading to a termination order.
New Balance Athletics, Inc. v.Nike, Inc.
New Balance Athletics' IPR challenge against Nike's footwear patent was denied by the PTAB. The Board rejected arguments of anticipation and obviousness, particularly regarding claim scope limitations like 'article of footwear.'
Skechers U.S.A., Inc. v.Nike, Inc.
Nike's footwear knitting patent survived Skechers' IPR challenge. The Board found no unpatentable claims after rejecting the obviousness arguments based on Reed and Nishida references.
Skechers U.S.A., Inc. v.Nike, Inc.
The PTAB institution of IPR2025-00141, filed by Skechers against Nike, moves forward to challenge the patent's validity on grounds of anticipation (102) and obviousness (103). The Board found that Petitioner demonstrated a reasonable likelihood of prevailing after vacating an initial discretionary denial.
Skechers U.S.A., Inc. v.Nike, Inc.
The PTAB denied Skechers' petition for IPR against Nike, finding that the petitioner failed to demonstrate material error regarding prior art already considered by the Examiner. This decision reinforces the strict application of the Advanced Bionics standard in discretionary denial proceedings.
Intersect ENT, Inc. et al. v.New Amsterdam, LLC
Intersect ENT and New Amsterdam settled their IPR dispute over U.S. Patent 6,916,483, filing a joint motion that led the PTAB to terminate the proceeding before trial.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.